(4S)-(-)-N-(1-Aminoethylidene)-3-(4-chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide

ID: ALA4093905

PubChem CID: 137653051

Max Phase: Preclinical

Molecular Formula: C24H21Cl2N5O2S

Molecular Weight: 514.44

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C/C(N)=N\C(=N/S(=O)(=O)c1ccc(Cl)cc1)N1C[C@H](c2ccccc2)C(c2ccc(Cl)cc2)=N1

Standard InChI:  InChI=1S/C24H21Cl2N5O2S/c1-16(27)28-24(30-34(32,33)21-13-11-20(26)12-14-21)31-15-22(17-5-3-2-4-6-17)23(29-31)18-7-9-19(25)10-8-18/h2-14,22H,15H2,1H3,(H2,27,28,30)/t22-/m1/s1

Standard InChI Key:  GZPQTZIUWCQXCF-JOCHJYFZSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   14.0272   -9.4633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4505   -9.4021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0762   -9.8742    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.3525   -4.4162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5026   -4.3207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8350   -8.3098    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.5009   -7.0442    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.2549   -3.6158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8138   -6.5863    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7202   -9.0215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2930   -9.0777    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   14.0565  -10.2876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0032   -4.3653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8629   -5.7568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7450   -3.6849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2679   -5.0420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1042   -7.9254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3115   -2.9821    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   15.4857  -10.2314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5713   -3.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1500   -6.5337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7864  -10.6720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8507   -4.3333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0849   -3.6075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0947   -5.0378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5333   -7.8693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2640   -8.2538    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.0388   -5.7931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2169  -10.6148    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   10.4059   -8.3660    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7866   -5.1161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6086   -5.0920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4948   -9.2881    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.0721   -7.1088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 16 25  2  0
 20 15  2  0
  5 24  2  0
 32 13  2  0
 17 30  1  0
 23 16  1  0
  4 31  2  0
 12 22  1  0
  7 26  1  0
 25  5  1  0
 26 27  2  0
 28 32  1  0
 13 20  1  0
 22 19  2  0
  8 23  2  0
  2 10  2  0
 33 11  2  0
 14 16  1  1
  9  7  1  0
 26  6  1  0
 11  3  2  0
 10  1  1  0
 19 29  1  0
 27 11  1  0
 15 18  1  0
  1 12  2  0
 14 28  1  0
  6 17  2  0
 28  9  2  0
 21 14  1  0
 19  2  1  0
  7 21  1  0
 31 32  1  0
 24  8  1  0
 15  4  1  0
 11  1  1  0
 17 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4093905

    ---

Associated Targets(Human)

KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cnr1 Cannabinoid CB1 receptor (739 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Brain (4203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (8163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella typhimurium (15756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 514.44Molecular Weight (Monoisotopic): 513.0793AlogP: 4.92#Rotatable Bonds: 4
Polar Surface Area: 100.48Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.85CX LogP: 4.50CX LogD: 3.93
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.39Np Likeness Score: -0.79

References

1. Iyer MR, Cinar R, Katz A, Gao M, Erdelyi K, Jourdan T, Coffey NJ, Pacher P, Kunos G..  (2017)  Design, Synthesis, and Biological Evaluation of Novel, Non-Brain-Penetrant, Hybrid Cannabinoid CB1R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver Fibrosis.,  60  (3): [PMID:28085283] [10.1021/acs.jmedchem.6b01504]

Source